Is fibromyalgia a neurologic disease?

被引：19

作者：

Bradley L.A. ^{[1
]}

McKendree-Smith N.L. ^{[1
]}

Alarcón G.S. ^{[1
]}

Cianfrini L.R. ^{[1
]}

机构：

[1] University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology, 475 Boshell Diabetes Building, 1808 7th Avenue South, Birmingham, 35294, AL

来源：

Current Pain and Headache Reports | 2002年 / 6卷 / 2期

关键词：

Fibromyalgia; Irritable Bowel Syndrome; Nerve Growth Factor; Pain Sensitivity; Rheumatol;

D O I：

10.1007/s11916-002-0006-9

中图分类号：

学科分类号：

摘要：

Fibromyalgia (FM) is characterized by abnormal pain sensitivity in response to diverse stimuli as well as persistent widespread pain and other symptoms such as fatigue and sleep disturbance. Progress has been made in identifying factors that contribute to the etiopathogenesis of abnormal pain sensitivity, but there is no single model of pathophysiology or treatment of FM that has gained wide acceptance among health care professionals. We review the literature on the etiopathogenesis of abnormal pain sensitivity in FM and describe an explanatory model that serves as a source of testable hypotheses in our laboratory. This model posits that interactions of exogenous (eg, environmental stressors) and endogenous (eg, neuroendocrine dysfunction) abnormalities in genetically predisposed individuals lead to a final common pathway, ie, alterations in central nervous system function and neuropeptide production that underlie central sensitization and abnormal pain sensitivity. This model also suggests that efforts to develop and evaluate treatments for FM should focus on interventions with direct or indirect effects on central functions that influence pain sensitivity. © 2002, Current Science Inc.

引用

页码：106 / 114

页数：8

共 86 条

[1]

Yunus M.B., Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome, Baillieres Clin Rheumatol, 8, pp. 811-837, (1994)

[2]

White K.P., Speechley M., Harth M., Ostbye T., The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario, J Rheumatol, 26, pp. 1570-1576, (1999)

[3]

Wolfe F., Ross K., Anderson J., Russell I.J., Hebert L., The prevalence and characteristics of fibromyalgia in the general population, Arthritis Rheum, 38, pp. 19-28, (1995)

[4]

Pellegrino M.J., Waylonis G.W., Sommer A., Familial occurrence of primary fibromyalgia, Arch Phys Med Rehabil, 70, pp. 61-63, (1989)

[5]

Buskila D., Neumann L., Hazanov I., Carmi R., Familial aggregation in the fibromyalgia syndrome, Semin Arthritis Rheum, 26, pp. 605-611, (1996)

[6]

Buskila D., Neumann L., Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM, J Rheumatol, 24, pp. 941-944, (1997)

[7]

Buskila D., Neumann L., Alhoashle A., Abu-Shakra M., Fibromyalgia syndrome in men, Semin Arthritis Rheum, 30, pp. 47-51, (2000)

[8]

Yunus M.B., Inanici F., Aldag J.C., Mangold R.F., Fibromyalgia in men: comparison of clinical features with women, J Rheumatol, 27, pp. 485-490, (2000)

[9]

Offenbaecher M., Bondy B., de Jonge S., Et al., Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region, Arthritis Rheum, 42, pp. 2482-2488, (1999)

[10]

Bengtsson A., Henriksson K.G., Larsson J., Muscle biopsy in primary fibromyalgia. Light-microscopical and histochemical findings, Scand J Rheumatol, 15, pp. 1-6, (1986)

← 1 2 3 4 5 6 7 8 9 →